Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19

Mingxing Huang, Man Li, Fei Xiao, Jiabi Liang, Pengfei Pang, Tiantian Tang, Shaoxuan Liu, Binghui Chen, Jingxian Shu, Yingying You, Yang Li, Meiwen Tang, Jianhui Zhou, Guanmin Jiang, Jingfen Xiang, Wenxin Hong, Songmei He, Zhaoqin Wang, Jianhua Feng, Changqing Lin, Yinong Ye, Zhilong Wu, Yaocai Li, Bei Zhong, Ruilin Sun, Zhongsi Hong, Jing Liu, Huili Chen, Xiaohua Wang, Zhonghe Li, Duanqing Pei, Lin Tian, Jinyu Xia, Shanping Jiang, Nanshan Zhong, Hong Shan
doi: https://doi.org/10.1101/2020.04.26.20081059
Mingxing Huang
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Man Li
2Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Xiao
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
2Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiabi Liang
3Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengfei Pang
2Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
4Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiantian Tang
5Department of Respiratory and Critical Care Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaoxuan Liu
6Clinical Research Center Office, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Binghui Chen
7Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingxian Shu
3Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yingying You
8Department of Oral and Maxillofacial Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Li
2Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meiwen Tang
9Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianhui Zhou
10Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guanmin Jiang
10Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingfen Xiang
11Department of Emergency, Wuhan East West Lake Mobile Cabin Hospitals, Wuhan, Hubei Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenxin Hong
12Department of Infectious Diseases, Guangzhou Eighth People’s Hospital, Guangzhou Province, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Songmei He
13Department of Infectious Diseases, Dongguan Ninth People’s Hospital, Dongguan, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaoqin Wang
14Department of Infectious Diseases, Shenzhen Third People’s Hospital, Shenzhen, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianhua Feng
15Department of Infectious Diseases, Zhongshan Second People’s Hospital, Zhongshan, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changqing Lin
16Department of Respiratory and Critical Care Medicine, Huizhou Central People’s Hospital, Huizhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yinong Ye
17Department of Infectious Diseases, Foshan First people’s Hospital, Foshan, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhilong Wu
18Department of Respiratory and Critical Care Medicine, Foshan Fourth People’s Hospital, Foshan, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaocai Li
19Department of Infectious Diseases, Maoming People’s Hospital, Maoming, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bei Zhong
20Department of Infectious Diseases, Qingyuan People’s Hospital, Qingyuan, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruilin Sun
21Department of Respiratory and Critical Care Medicine, Guangdong Second People’s Hospital, Guangzhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhongsi Hong
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Liu
22Department of Respiratory and Critical Care Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huili Chen
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohua Wang
23Intensive Care Unit, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhonghe Li
24Department of Nephropathy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duanqing Pei
25Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, Guangdong Province, China
26Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
Lin Tian
3Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
Jinyu Xia
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
Shanping Jiang
5Department of Respiratory and Critical Care Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
Nanshan Zhong
27State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
Hong Shan
1Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
2Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shanhong@mail.sysu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Effective therapies are urgently needed for the SARS-CoV-2 pandemic. Chloroquine has been proved to have antiviral effect against coronavirus in vitro. In this study, we aimed to assess the efficacy and safety of chloroquine with different doses in COVID-19.

Method In this multicenter prospective observational study, we enrolled patients older than 18 years old with confirmed SARS-CoV-2 infection excluding critical cases from 12 hospitals in Guangdong and Hubei Provinces. Eligible patients received chloroquine phosphate 500mg, orally, once (half dose) or twice (full dose) daily. Patients treated with non-chloroquine therapy were included as historical controls. The primary endpoint is the time to undetectable viral RNA. Secondary outcomes include the proportion of patients with undetectable viral RNA by day 10 and 14, hospitalization time, duration of fever, and adverse events.

Results A total of 197 patients completed chloroquine treatment, and 176 patients were included as historical controls. The median time to achieve an undetectable viral RNA was shorter in chloroquine than in non-chloroquine (absolute difference in medians −6.0 days; 95% CI −6.0 to −4.0). The duration of fever is shorter in chloroquine (geometric mean ratio 0.6; 95% CI 0.5 to 0.8). No serious adverse events were observed in the chloroquine group. Patients treated with half dose experienced lower rate of adverse events than with full dose.

Conclusions Although randomised trials are needed for further evaluation, this study provides evidence for safety and efficacy of chloroquine in COVID-19 and suggests that chloroquine can be a cost-effective therapy for combating 102 the COVID-19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by National key Research and Development (R&D plan “public security risk prevention and control and emergency technical equipment”: Novel coronavirus infection pneumonia diagnosis and control key technology research (2020YFC082400), Guangdong Research and Development (R&D) Program in Key Areas: Guangdong Scientific and Technological Research Special fund for Prevention and Treatment of COVID-19, Special fund for emergency research on SARS-CoV-2 from the Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Cultivation Project of “Three Major Scientific Research Projects” of Sun Yat-sen University in 2020, Emergency Project of New Coronavirus Prevention and Control Science and Technology of Sun Yat-sen University, and Zhuhai 2020 “novel coronavirus infection control” emergency technology tackling key issues. We thank all the participants in this study. We acknowledge all health-care workers who provided care for the patients at the 12 hospitals.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author on reasonable request. Participant data without names and identifiers will be made available after approval from the corresponding author and Ministry of science and technology and Health Committee in Guangdong province. After publication of study findings, the data will be available for others to request. The research team will provide an email address for communication once the data are approved to be shared with others. The proposal with detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability to request for our data. The corresponding author and Ministry of science and technology and Health Committee in Guangdong province will make a decision based on these materials. Additional materials may also be required during the process.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
Mingxing Huang, Man Li, Fei Xiao, Jiabi Liang, Pengfei Pang, Tiantian Tang, Shaoxuan Liu, Binghui Chen, Jingxian Shu, Yingying You, Yang Li, Meiwen Tang, Jianhui Zhou, Guanmin Jiang, Jingfen Xiang, Wenxin Hong, Songmei He, Zhaoqin Wang, Jianhua Feng, Changqing Lin, Yinong Ye, Zhilong Wu, Yaocai Li, Bei Zhong, Ruilin Sun, Zhongsi Hong, Jing Liu, Huili Chen, Xiaohua Wang, Zhonghe Li, Duanqing Pei, Lin Tian, Jinyu Xia, Shanping Jiang, Nanshan Zhong, Hong Shan
medRxiv 2020.04.26.20081059; doi: https://doi.org/10.1101/2020.04.26.20081059
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
Mingxing Huang, Man Li, Fei Xiao, Jiabi Liang, Pengfei Pang, Tiantian Tang, Shaoxuan Liu, Binghui Chen, Jingxian Shu, Yingying You, Yang Li, Meiwen Tang, Jianhui Zhou, Guanmin Jiang, Jingfen Xiang, Wenxin Hong, Songmei He, Zhaoqin Wang, Jianhua Feng, Changqing Lin, Yinong Ye, Zhilong Wu, Yaocai Li, Bei Zhong, Ruilin Sun, Zhongsi Hong, Jing Liu, Huili Chen, Xiaohua Wang, Zhonghe Li, Duanqing Pei, Lin Tian, Jinyu Xia, Shanping Jiang, Nanshan Zhong, Hong Shan
medRxiv 2020.04.26.20081059; doi: https://doi.org/10.1101/2020.04.26.20081059

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)